Flecainide Shortage Update: What Patients Need to Know in 2026

Flecainide (Tambocor) is a critical heart rhythm medication used by hundreds of thousands of Americans to manage atrial fibrillation, paroxysmal SVT, and ventricular arrhythmias. When supply disruptions occur — even localized ones — patients face real health risks. Here's what the availability picture looks like in 2026 and what you should know.

Flecainide Shortage Status in 2026

As of 2026, flecainide is not listed as an active nationwide shortage by the FDA's Drug Shortages Database. The generic has been commercially available since 2004 when Tambocor's original patent expired, and multiple manufacturers currently produce it. This makes a complete national shortage unlikely in the near term.

However, many patients across the country are still running into real-world availability issues at specific pharmacies. "No official shortage" does not mean "easy to find everywhere." Localized stock-outs — particularly for the 50 mg tablet strength — are a documented and ongoing challenge.

Has Flecainide Ever Been in Shortage Before?

Yes. Flecainide has appeared on the FDA shortage list in the past. Historical shortage periods have been tied to manufacturing disruptions, raw material sourcing issues, and quality control holds at generic manufacturing facilities. These events tend to be temporary, but for patients who depend on the medication daily, even a two-week shortage can be medically dangerous.

Flecainide is the kind of medication where continuity of supply matters enormously. Unlike a blood pressure medication where missing a few doses causes a gradual increase in BP, stopping flecainide abruptly can allow a serious arrhythmia to return within hours.

Why Pharmacy-Level Stock Gaps Still Happen

Even without a formal FDA shortage, individual pharmacies run out of flecainide regularly. The reasons include:

• Generic market consolidation. While several companies produce generic flecainide, most retail pharmacies source from a limited number of large pharmaceutical distributors. Disruptions at any point in that chain affect many pharmacies simultaneously.
• Strength-specific gaps. Flecainide comes in 50 mg, 100 mg, and 150 mg tablets. A pharmacy may have one or two strengths in stock but not the third. Patients on 50 mg doses tend to face the most frequent gaps.
• Low stocking priority. Compared to high-volume drugs like metformin or atorvastatin, flecainide is a specialized cardiac medication. Pharmacies don't stock it in large quantities, and a small increase in demand can quickly outpace supply.
• Geographic disparities. Rural areas with fewer pharmacies are disproportionately affected. If the one or two local pharmacies are out of stock, patients may need to drive long distances or wait for a mail-order shipment.

What Does Flecainide's Availability Look Like Going Forward?

Industry projections suggest stable to slightly declining prices for generic flecainide through 2026–2028, driven by a competitive generic market and stable demand from the large atrial fibrillation patient population. A new national shortage is not anticipated, but localized pharmacy gaps will almost certainly continue.

The underlying demand drivers — particularly the growing prevalence of AFib in an aging U.S. population — will support continued availability of flecainide as a generic. However, the same fragile supply chain dynamics that cause current gaps are not going away.

What Should Patients Do Right Now?

Given the real possibility of stock gaps at any individual pharmacy, here are the most important steps flecainide patients should take:

1. Refill early. Begin checking pharmacy availability at least 5–7 days before you run out.
2. Know your backup pharmacy. Identify 2–3 pharmacies near you that consistently stock flecainide before you ever need them in a pinch.
3. Consider a 90-day supply. Filling a 90-day supply (often available through mail-order pharmacies or large chains) reduces how often you need to refill and provides more buffer time.
4. Use medfinder when supply is tight. medfinder calls pharmacies near you to check which ones have your medication in stock and texts you the results — saving you hours of phone calls.
5. Never stop flecainide without calling your cardiologist. If you genuinely cannot find it in time, your cardiologist needs to know immediately. Do not simply stop taking it — the risk of arrhythmia recurrence is real.

How to Check the Latest FDA Shortage Status

The FDA maintains a public Drug Shortages Database at fda.gov/drugs/drug-shortages. You can search for flecainide by generic or brand name (Tambocor) to see if any shortage has been reported. Check it periodically, especially if your pharmacy is having trouble sourcing your supply.

The Bottom Line on Flecainide Availability in 2026

Flecainide is not in a formal national shortage in 2026, but pharmacy-level gaps are real and can have serious health consequences for patients who depend on it. Being proactive — refilling early, knowing your backup pharmacies, and using tools like medfinder — is the best defense. See our full guide on how to find flecainide in stock near you for practical next steps.